Big Pharma Split Corp.
Distributions
(For the purposes of the Income Tax Act (Canada) and any corresponding provincial or territorial legislation, all dividends paid by Big Pharma Split Corp. on its Class A Shares and Preferred Shares are “eligible dividends”, unless otherwise indicated.)
| Last Distribution Per Unit (Class A): | $0.1031 |
| Last Ex-dividend Date (Class A): | 2024/11/29 |
| Last Record Date (Class A): | 2024/11/29 |
| Distribution Frequency (Class A): | Monthly |
| Distributions Since Inception* (Class A): | $9.4497 |
| Last Distribution Per Unit (Preferred Share): | $0.1250 |
| Last Ex-dividend Date (Preferred Share): | 2024/09/27 |
| Last Record Date (Preferred Share): | 2024/09/27 |
| Distribution Frequency (Preferred Share): | Quarterly |
| Distributions Since Inception* (Preferred Share): | $3.4266 |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2024/11/29 | 2024/11/29 | 2024/12/09 | $0.1031 | Monthly | ||
| 2024/10/31 | 2024/10/31 | 2024/11/08 | $0.1031 | Monthly | ||
| 2024/09/27 | 2024/09/27 | 2024/10/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2024/08/30 | 2024/08/30 | 2024/09/09 | $0.1031 | Monthly | ||
| 2024/07/31 | 2024/07/31 | 2024/08/09 | $0.1031 | Monthly | ||
| 2024/06/28 | 2024/06/28 | 2024/07/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2024/05/31 | 2024/05/31 | 2024/06/07 | $0.1031 | Monthly | ||
| 2024/04/29 | 2024/04/30 | 2024/05/09 | $0.1031 | Monthly | ||
| 2024/03/27 | 2024/03/28 | 2024/04/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2024/02/28 | 2024/02/29 | 2024/03/08 | $0.1031 | Monthly | ||
| 2024/02/21 | 2024/02/22 | 2024/02/26 | $0.0733 | Special | ||
| 2024/01/30 | 2024/01/31 | 2024/02/09 | $0.1031 | Monthly |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2023/12/28 | 2023/12/29 | 2024/01/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2023/11/29 | 2023/11/30 | 2023/12/08 | $0.1031 | Monthly | ||
| 2023/10/30 | 2023/10/31 | 2023/11/09 | $0.1031 | Monthly | ||
| 2023/09/28 | 2023/09/29 | 2023/10/06 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2023/08/30 | 2023/08/31 | 2023/09/08 | $0.1031 | Monthly | ||
| 2023/07/28 | 2023/07/31 | 2023/08/09 | $0.1031 | Monthly | ||
| 2023/06/29 | 2023/06/30 | 2023/07/07 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2023/05/30 | 2023/05/31 | 2023/06/09 | $0.1031 | Monthly | ||
| 2023/04/27 | 2023/04/28 | 2023/05/09 | $0.1031 | Monthly | ||
| 2023/03/30 | 2023/03/31 | 2023/04/06 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2023/02/27 | 2023/02/28 | 2023/03/09 | $0.1031 | Monthly | ||
| 2023/01/30 | 2023/01/31 | 2023/02/09 | $0.1031 | Monthly |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2022/12/29 | 2022/12/30 | 2023/01/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2022/11/29 | 2022/11/30 | 2022/12/09 | $0.1031 | Monthly | - | |
| 2022/10/28 | 2022/10/31 | 2022/11/09 | $0.1031 | Monthly | - | |
| 2022/09/28 | 2022/09/29 | 2022/10/07 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2022/08/30 | 2022/08/31 | 2022/09/09 | $0.1031 | Monthly | - | |
| 2022/07/28 | 2022/07/29 | 2022/08/09 | $0.1031 | Monthly | - | |
| 2022/06/29 | 2022/06/30 | 2022/07/08 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2022/05/30 | 2022/05/31 | 2022/06/09 | $0.1031 | Monthly | - | |
| 2022/04/28 | 2022/04/29 | 2022/05/09 | $0.1031 | Monthly | - | |
| 2022/03/30 | 2022/03/31 | 2022/04/08 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2022/02/25 | 2022/02/28 | 2022/03/09 | $0.1031 | Monthly | - | |
| 2022/01/28 | 2022/01/31 | 2022/02/09 | $0.1031 | Monthly | - |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2021/12/30 | 2021/12/31 | 2022/01/07 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2021/11/29 | 2021/11/30 | 2021/12/09 | $0.1031 | Monthly | - | |
| 2021/10/28 | 2021/10/29 | 2021/11/09 | $0.1031 | Monthly | - | |
| 2021/09/28 | 2021/09/29 | 2021/10/08 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2021/08/30 | 2021/08/31 | 2021/09/09 | $0.1031 | Monthly | - | |
| 2021/07/29 | 2021/07/30 | 2021/08/09 | $0.1031 | Monthly | - | |
| 2021/06/29 | 2021/06/30 | 2021/07/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2021/05/28 | 2021/05/31 | 2021/06/09 | $0.1031 | Monthly | - | |
| 2021/04/29 | 2021/04/30 | 2021/05/07 | $0.1031 | Monthly | - | |
| 2021/03/30 | 2021/03/31 | 2021/04/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2021/02/18 | 2021/02/19 | 2021/02/24 | $0.7160 | Special | - | |
| 2021/02/25 | 2021/02/26 | 2021/03/09 | $0.1031 | Monthly | - | |
| 2021/01/28 | 2021/01/29 | 2021/02/09 | $0.1031 | Monthly | - |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2020/12/30 | 2020/12/31 | 2021/01/08 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2020/11/27 | 2020/11/30 | 2020/12/09 | $0.1031 | Monthly | - | |
| 2020/10/29 | 2020/10/30 | 2020/11/09 | $0.1031 | Monthly | - | |
| 2020/09/29 | 2020/09/30 | 2020/10/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2020/08/28 | 2020/08/31 | 2020/09/09 | $0.1031 | Monthly | - | |
| 2020/07/30 | 2020/07/31 | 2020/08/07 | $0.1031 | Monthly | - | |
| 2020/06/29 | 2020/06/30 | 2020/07/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2020/05/28 | 2020/05/29 | 2020/06/09 | $0.1031 | Monthly | - | |
| 2020/04/29 | 2020/04/30 | 2020/05/08 | $0.1031 | Monthly | - | |
| 2020/03/30 | 2020/03/31 | 2020/04/09 | $0.1031 | Monthly | $0.1250 | Quarterly |
| 2020/02/27 | 2020/02/28 | 2020/03/09 | $0.1031 | Monthly | - | |
| 2020/01/30 | 2020/01/31 | 2020/02/07 | $0.1031 | Monthly | - |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2019/12/30 | 2019/12/31 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2019/11/28 | 2019/11/29 | $0.1031 | Monthly | - | ||
| 2019/10/30 | 2019/10/31 | $0.1031 | Monthly | - | ||
| 2019/09/27 | 2019/09/30 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2019/08/29 | 2019/08/30 | $0.1031 | Monthly | - | ||
| 2019/07/30 | 2019/07/31 | $0.1031 | Monthly | - | ||
| 2019/06/27 | 2019/06/28 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2019/05/30 | 2019/05/31 | $0.1031 | Monthly | - | ||
| 2019/04/29 | 2019/04/30 | $0.1031 | Monthly | - | ||
| 2019/03/28 | 2019/03/29 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2019/02/27 | 2019/02/28 | $0.1031 | Monthly | - | ||
| 2019/01/30 | 2019/01/31 | $0.1031 | Monthly | - |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2018/12/28 | 2018/12/31 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2018/11/29 | 2018/11/30 | $0.1031 | Monthly | - | ||
| 2018/10/30 | 2018/10/31 | $0.1031 | Monthly | - | ||
| 2018/09/27 | 2018/09/28 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2018/08/30 | 2018/08/31 | $0.1031 | Monthly | - | ||
| 2018/07/30 | 2018/07/31 | $0.1031 | Monthly | - | ||
| 2018/06/28 | 2018/06/29 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2018/05/30 | 2018/05/31 | $0.1031 | Monthly | - | ||
| 2018/04/27 | 2018/04/30 | $0.1031 | Monthly | - | ||
| 2018/03/28 | 2018/03/29 | $0.1031 | Monthly | $0.1250 | Quarterly | |
| 2018/02/27 | 2018/02/28 | $0.1031 | Monthly | - | ||
| 2018/01/30 | 2018/01/31 | $0.1031 | Monthly | - |
| Ex-dividend Date | Record Date | Payment Date | Class A Share | Distribution Frequency | Preferred Share | Distribution Frequency |
|---|---|---|---|---|---|---|
| 2017/12/28 | 2017/12/29 | $0.1031 | Monthly | $0.0516 | Quarterly |
* Since Inception Date: Class A is 2017/11/24; Preferred Share is 2017/11/24.
2024
September 30, 2024 Quarterly Portfolio Disclosure
June 30, 2024 Interim Financial Statements | English
June 30, 2024 Interim Management Report of Fund Performance | English
June 30, 2024 Interim Financial Statements | French
June 30, 2024 Interim Management Report of Fund Performance | French
March 31, 2024 Quarterly Portfolio Disclosure
2023
December 31, 2023 Annual Financial Statements | English
December 31, 2023 Annual Management Report of Fund Performance | English
December 31, 2023 Annual Financial Statements | French
December 31, 2023 Annual Management Report of Fund Performance | French
September 30, 2023 Quarterly Portfolio Disclosure
June 30, 2023 Interim Financial Statements | English
June 30, 2023 Interim Management Report of Fund Performance | English
June 30, 2023 Interim Financial Statements | French
June 30, 2023 Interim Management Report of Fund Performance | French
March 31, 2023 Quarterly Portfolio Disclosure
2022
December 31, 2022 Annual Financial Statements | English
December 31, 2022 Annual Management Report of Fund Performance | English
December 31, 2022 Annual Financial Statements | French
December 31, 2022 Annual Management Report of Fund Performance | French
September 30, 2022 Quarterly Portfolio Disclosure
June 30, 2022 Interim Financial Statements | English
June 30, 2022 Interim Management Report of Fund Performance | English
June 30, 2022 Interim Financial Statements | French
June 30, 2022 Interim Management Report of Fund Performance | French
2021
December 31, 2021 Annual Financial Statements | English
December 31, 2021 Annual Management Report of Fund Performance | English
December 31, 2021 Annual Financial Statements | French
December 31, 2021 Annual Management Report of Fund Performance | French
September 30, 2021 Quarterly Portfolio Disclosure
June 30, 2021 Interim Financial Statements | English
June 30, 2021 Interim Management Report of Fund Performance | English
June 30, 2021 Interim Financial Statements | French
June 30, 2021 Interim Management Report of Fund Performance | French
March 31, 2021 Quarterly Portfolio Disclosure
2020
December 31, 2020 Annual Financial Statements | English
December 31, 2020 Annual Management Report of Fund Performance | English
December 31, 2020 Annual Financial Statements | French
December 31, 2020 Annual Management Report of Fund Performance | French
September 30, 2020 Quarterly Portfolio Disclosure
June 30, 2020 Interim Financial Statements | English
June 30, 2020 Interim Management Report of Fund Performance | English
June 30, 2020 Interim Financial Statements | French
June 30, 2020 Interim Management Report of Fund Performance | French
March 31, 2020 Quarterly Portfolio Disclosure
2019
December 31, 2019 Annual Financial Statements | English**
December 31, 2019 Annual Management Report of Fund Performance | English **
December 31, 2019 Annual Financial Statements | French**
December 31, 2019 Annual Management Report of Fund Performance | French**
September 30, 2019 Quarterly Portfolio Disclosure
June 30, 2019 Interim Financial Statements | English
June 30, 2019 Interim Management Report of Fund Performance | English
June 30, 2019 Interim Financial Statements | French
June 30, 2019 Interim Management Report of Fund Performance | French
June 30, 2019 Quarterly Portfolio Disclosure
March 31, 2019 Quarterly Portfolio Disclosure
2018
December 31, 2018 Annual Financial Statements | English
December 31, 2018 Annual Management Report of Fund Performance | English
December 31, 2018 Annual Financial Statements | French
December 31, 2018 Annual Management Report of Fund Performance | French
December 31, 2018 Quarterly Portfolio Disclosure
September 30, 2018 Quarterly Portfolio Disclosure
June 30, 2018 Interim Financial Statements | English
June 30, 2018 Interim Management Report of Fund Performance | English
June 30, 2018 Interim Financial Statements | French
June 30, 2018 Interim Management Report of Fund Performance | French
March 31, 2018 Quarterly Portfolio Disclosure
2022
December 9, 2022 Harvest Portfolios Group Inc. Establishes At-The-Market Equity Program for Big Pharma Split Corp.
October 24, 2022 Harvest Portfolios Group Inc. Extends Big Pharma Split Corp. Maturity Date; Announces Appointment to Board of Directors
October 21, 2022 Harvest Declares Big Pharma Split Corp. October 2022 Distribution
September 21, 2022 Harvest Declares Big Pharma Split Corp. September 2022 Distribution
2021
June 7, 2021 Harvest Portfolios Group Inc. Establishes At-The-Market Equity Program for Big Pharma Split Corp.
May 21, 2021 Harvest Declares Big Pharma Split Corp. May 2021 Distribution
Apr 19, 2021 Harvest Declares Big Pharma Split Corp. April 2021 Distribution
Mar 4, 2021 Harvest Portfolios Group Inc. Completes $9.3 million Overnight Offering for Big Pharma Split Corp.
Feb 25, 2021 Harvest Portfolios Group Inc. Announces $9.3 million Overnight Offering for Big Pharma Split Corp.
Feb 24, 2021 Harvest Portfolios Group Inc. Announces Big Pharma Split Corp. Overnight Offering
Feb 11, 2021 Harvest Portfolios Group Inc. Declares Big Pharma Split Corp. Class A Special Capital Gains Distribution
2018
June 20, 2018 Harvest declares Big Pharma Split Corp. Distributions June 2018
May 22, 2018 Harvest Portfolios Groups Inc. Declares Big Pharma Split Corp. Class A May 2018 Distribution
April 20, 2018 Harvest Portfolios Groups Inc. Declares Big Pharma Split Corp. Class A April 2018 Distribution
March 20, 2018 Harvest Declares Big Pharma Split Corp. Class A and Preferred March 2018 Distributions
February 21, 2018 Harvest Declares Big Pharma Split Corp. Class A February 2018 Distribution
January 19, 2018 Big Pharma Split Corp. Declares January 2018 Distributions
2017
November 24, 2017 Big Pharma Split Corp. closes $34 million Initial Public Offering
October 30, 2017 Big Pharma Split Corp. Files Final Prospectus
September 26, 2017 Big Pharma Split Corp. Announces Filing of Preliminary Prospectus
2023
2022
2021
2020
2019
| STRUCTURED FUNDS (as at 2024/12/09) |
| Symbol | Class | NAV | Recent Distribution | Current Yield* |
|---|---|---|---|---|
| Class A Share | $12.60 | $0.1031 / MTH | 9.38% |
| Preferred Share | $10.00 | $0.1250 / QTR | 5.01% |
Why Invest In This Fund?
Big Pharma Split Corp. will invest in an initially equally-weighted portfolio comprised of Equity Securities of ten issuers, selected by the Portfolio Manager from the Investable Universe, that at the time of investment and immediately following each semi-annual reconstitution and rebalancing: (i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its Equity Securities that, in the opinion of the Portfolio Manager, are sufficiently liquid to permit the Portfolio Manager to write options in respect of such securities. The Portfolio will be comprised primarily of the largest (as determined by market capitalization calculated in US$) Pharmaceutical Issuers in the Investable Universe.
The Manager will hedge substantially all of the Portfolio’s U.S dollar exposure back to the Canadian dollar.
The Class A Shares provide holders a monthly cash distribution and are targeted to be $0.1031 per share and, for the Preferred Shares, quarterly cash distributions are fixed at $0.1250 per share.
Fund Quick Facts
As at November 29, 2024
| TSX Code | PRM | PRM.PR.A |
| Cusip PRM | 08934P108 |
| Cusip PRM.PR.A | 08934P207 |
| Total AUM | $25.9 million |
| Management Fee | 0.75% |
| Number of Equity Securities | 10 |
| Income Distribution PRM | Monthly |
| Income Distribution PRM.PR.A | Quarterly |
| Distribution PRM | $0.1031 |
| Distribution PRM.PR.A | $0.1250 |
| Current Yield - PRM | 9.30% |
| Distribution Method | Cash |
| RSP Eligible | RRSP/RRIF/RESP/TFSA |
Portfolio Holdings
As at November 29, 2024| Name | Ticker | Weight | Sector | Country |
|---|---|---|---|---|
| Johnson & Johnson | JNJ US | 10.7% | Pharmaceuticals | United States |
| AbbVie Inc. | ABBV US | 10.4% | Biotechnology | United States |
| Amgen Inc. | AMGN US | 10.0% | Biotechnology | United States |
| Pfizer Inc. | PFE US | 10.0% | Pharmaceuticals | United States |
| Merck & Co., Inc. | MRK US | 9.8% | Pharmaceuticals | United States |
| Sanofi | SNY US | 9.8% | Pharmaceuticals | United States |
| Eli Lilly and Company | LLY US | 9.5% | Pharmaceuticals | United States |
| AstraZeneca PLC | AZN US | 9.4% | Pharmaceuticals | United States |
| Bristol-Myers Squibb Company | BMY US | 9.1% | Pharmaceuticals | United States |
| GSK PLC | GSK US | 9.1% | Pharmaceuticals | United States |
| Cash and other assets and liabilities | 2.6% | |||
| Foreign currency forwards | (0.1)% | |||
| Market value of options | (0.2)% |
Sub-Sector Allocation
As at November 29, 2024Performance (%)
As at November 30, 2024| Symbol | 1M | 3M | 6M | YTD | 1Y | 2Y | 3Y | 4Y | 5Y | 7Y | SI |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRM | (8.38) | (17.81) | (4.18) | 0.99 | 6.49 | (3.15) | 7.79 | 8.25 | 7.54 | 8.76 | 8.90 |
| PRM.PR.A | 0.00 | 1.25 | 2.52 | 3.80 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 4.99 | 4.97 |
| Symbol | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| PRM | (3.42) | 10.95 | 23.13 | 0.24 | 20.21 | 11.81 | 1.36 |
| PRM.PR.A | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 0.52 |
Cumulative Growth $10,000 Invested
(NAV pricing)
The “Growth of $10,000 invested” chart shows the final value of a hypothetical $10,000 investment in securities in this class/series of the fund as at the end of the investment period indicated and is not intended to reflect future values or returns on investment in such securities.
Disclaimer
The information contained herein is not an offer to sell nor a solicitation to buy the aforementioned security. You will usually pay brokerage fees to your investment dealer if you purchase or sell Class A shares or Preferred shares of Big Pharma Split Corp. (the “Fund”) on the TSX. If shares are purchased or sold on the TSX, investors may pay more than the current net asset value when buying shares of the Fund and may receive less than the current net asset value when selling them. There are ongoing fees and expenses associated with owning shares of an investment fund. An investment fund must prepare disclosure documents that contain key information about the fund. You can find more detailed information about the fund in these documents. The indicated rates of return are the historical annual compounded total returns including changes in unit value and reinvestment of all distributions and do not take into account income taxes payable by any securityholder that would have reduced returns. Investment funds are not guaranteed, their values change frequently and past performance may not be repeated. Distributions are paid to you in cash from the Class A shares or Preferred shares of the Fund. If the Fund earns less than the amount distributed, the difference is a return of capital. The current yield is calculated based on the market price of the Fund. Big Pharma Split Corp. is managed by Harvest Portfolios Group Inc.
The current yield represents an annualized amount that is comprised of 12 unchanged monthly distributions (using the most recent month’s distribution figure multiplied by 12) as a percentage of the closing market price of the Fund. The current yield does not represent historical returns of the Fund but represents the distribution an investor would receive if the most recent distribution stayed the same going forward.
**Filed on SEDAR April 01, 2020 per NI 81-503 Extension of Certain Filing, Delivery and Prospectus Renewal Requirements of Investment Funds.
† The first year of Calendar Year Performance presents the rate of return from commencement of operations to December 31 of that year.
